Ontology highlight
ABSTRACT: Background
Glucocorticoids play an essential part in anti-leukemic therapies, but resistance is a crucial event for the prognosis of the disease. Glucocorticoids influence the metabolic properties of leukemic cells. The inherent plasticity of clinically evolving cancer cells justifies the characterization of drug-induced early oncogenic pathways, which represent a likely source of detrimental secondary effects.Aim
The present work aims to investigate the effect of glucocorticoids in metabolic pathways in the CCRF-CEM leukemic cells. Metabolic factors and gene expression profiles were examined in order to unravel the possible mechanisms of the CCRF-CEM leukemic cell growth dynamics.Methods
CCRF-CEM cells were used as a model. Cells were treated with prednisolone with
SUBMITTER: Lambrou GI
PROVIDER: S-EPMC8198442 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature